-
Cantor Fitzgerald Reiterates "Neutral" Rating for CRISPR Therapeutics (NASDAQ:CRSP)
来源: Buzz FX / 19 2月 2025 11:02:12 America/New_York
Cantor Fitzgerald Reiterates "Neutral" Rating for CRISPR Therapeutics (NASDAQ:CRSP) Written by MarketBeat February 19, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "neutral" rat
Read more...